Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evidence generation, and harmonize data. Its platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating agile clinical trials; and extensive configuration to support virtually any phase of clinical study and any indication. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.

Science 37 Holdings, Inc.

Science 37 is a virtual clinical trial company that focuses on enhancing the quality of clinical research by improving patient access and enrollment, emphasizing diversity in patient populations.

NASDAQ:SNCE

Science 37

Last Close

5.73

11/03 20:00

Market Cap

34.66M

Beta: 1.33

Volume Today

48.81K

Avg: 731.49K

PE Ratio

−5.44

PFCF: −0.47